West Pharmaceutical Services Inc. Stock
The West Pharmaceutical Services Inc. stock is trending slightly upwards today, with an increase of €2.10 (0.930%) compared to yesterday's price.
With 12 Buy predictions and not the single Sell prediction the community is currently very high on West Pharmaceutical Services Inc..
As a result the target price of 297 € shows a positive potential of 30.32% compared to the current price of 227.9 € for West Pharmaceutical Services Inc..
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | 0.930% | -0.921% | 12.450% | 19.947% | -3.628% | -31.782% | -13.087% |
| Haemonetics Corp. | 1.940% | 6.275% | 0.962% | - | -23.358% | - | - |
| Bio-Rad Labs Inc. A | -1.910% | 4.326% | 7.455% | 15.470% | -2.753% | -42.477% | -51.301% |
| CONMED Corp. | 0.000% | 7.051% | 3.086% | -25.112% | -4.571% | -66.091% | -69.358% |
Comments
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for WST provided by MarketBeat